Irish Stones wrote: » I binge watched several TV programs a couple of days ago, all focused on the virus and vaccine subjects. The presenter of one of those programs asked a doctor involved in the emergency team why the rollout date for the vaccine keeps moving forward. It was October, then it became November, then the end of the year, and so on. His answer was that in time of desperation and grimness, people need some hope, need to see some light at the end of the tunnel. Governments' task is to give people some comfort and a bit of hope, so governments keep saying that the vaccine is on the way just to keep people quiet and positive. Truth is, according to this doctor, that no vaccine is near, that no data is available on Phase 3 of studies, so there is no official and sure rollout date yet. His words were that it is possible that something might be available late April, and anyway no end of pandemic is possible before beginning 2023. Those were his words. I've been trying to retrieve the footage on the web, but because I watched many programs all day long, I can't remember what program it was, can't remember the time of the day and maybe I am wrong on the day too (Saturday or Friday?)...
Mark1916 wrote: » https://www.wsj.com/articles/covid-19-vaccine-from-pfizer-and-biontech-works-better-than-expected-11604922300 A vaccine developed by Pfizer Inc. PFE 0.03% and partner BioNTech SE proved better than expected at protecting people from Covid-19 in a pivotal study, a milestone in the hunt for shots that can stop the global pandemic. The vaccine proved to be more than 90% effective in the first 94 subjects who were infected by the new coronavirus and developed at least one symptom, the companies said Monday
Hmmzis wrote: » Paywalled for me but is that phase 3 data we're seeing reported on? If so, happy days!
stephenjmcd wrote: » Yup, interim efficacy analysis conducted on November 8, 2020 by an external, independent Data Monitoring Committee (DMC) from the Phase 3 clinical study.https://investors.pfizer.com/investor-news/press-release-details/2020/Pfizer-and-BioNTech-Announce-Vaccine-Candidate-Against-COVID-19-Achieved-Success-in-First-Interim-Analysis-from-Phase-3-Study/default.aspx "After discussion with the FDA, the companies recently elected to drop the 32-case interim analysis and conduct the first interim analysis at a minimum of 62 cases. Upon the conclusion of those discussions, the evaluable case count reached 94 and the DMC performed its first analysis on all cases. The case split between vaccinated individuals and those who received the placebo indicates a vaccine efficacy rate above 90%, at 7 days after the second dose. This means that protection is achieved 28 days after the initiation of the vaccination"
VG31 wrote: » Surely with 90% efficacy there should be zero excuse for restrictions on social distancing, masks, large gatherings etc not to be dropped (gradually of course)?
igCorcaigh wrote: » And the obligatory note of caution:https://twitter.com/anamatics/status/1325770355873558528?s=19
Harry Palmr wrote: » Assuming this is confirmed with more work it'll show that vaccines only take a long time due to lack of an imperative - which is to say if it's something with very low serious sickness/fatality level or is most likely to effect poor people in lands far away big pharma will take it's own sweet time or just not bother at all.
opinionated3 wrote: » Sky news has it now as breaking news. Please let this be the one. Any idea if the EU has access booked to this vaccine?
Harry Palmr wrote: » As an aside Zoom stock market valuation is plummeting!
Gael23 wrote: » Can they produce 100m per month?
landofthetree wrote: » Pfizer VP Paul Duffy told@VirginMediaNews last week the company already had plans to manufacture 100m of these vaccines this year, and 1.3 billion by the end of 2021
